Cell and Gene Therapy Conference: Meet us in 2025 and unlock the full potential of your cell and gene therapies

Cell and Gene Therapy Conferences in 2025: Connect with our experts and find out how to unlock the full potential of your cell and gene therapies.

Connect with Intertek's gene therapy characterization experts during the premier international C&G events this year and beyond. We look forward to discussing the latest breakthroughs in discovery, clinical development, novel modalities, and much more with you. We can support your gene therapy development from an early stage, providing a broad range of cGMP, GLP, and GCP laboratory services, including method development, validation, and analysis to meet milestone and regulatory requirements. 

Explore expert strategies for overcoming development hurdles, forging strategic partnerships, and unlocking the full potential of your cell and gene therapies. 


Meet us at the following conferences and dive into our cell and gene therapy insights:

Advanced Therapies Europe 2025 Barcelona, Spain (September 2-4, 2025)

Cell & Gene Therapy International Boston, MA (September 16-18, 2025, Biotech Week Boston)
Request Conference presentation: AAV Therapies – Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization | Presented by Shaun Smith, Senior Scientist at Intertek Pharmaceutical Services | 18 Sep, 12:15 pm


Inhaled & Nasal Biologics | DNA Forum 2025 Cambridge, UK (September 25-26, 2025) - Secure your place today - registration is live!

Gene Therapy Analytical Development Summit Boston, MA (October 21-23, 2025)

Advanced Therapies Week San Diego, CA (February 9-12, 2026) 



Request our presentation slides:

Cell & Gene International 2025 presentation: AAV Therapies – Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization

Comprehensive characterization of AAV8 critical quality attributes (CQAs), specifically empty and full capsids, was performed using orthogonal techniques including AUC, cryo-TEM, MADLS, ELISA, CE, and SEC. Each method provided unique insights into capsid composition and product quality. Together, this analytical strategy allowed for a robust assessment of vector quality to support regulatory submissions. Shaun Smith will present this talk during the C&G International conference in Boston. Can’t make it to the conference? You can still access the slides, just complete this quick form to request a copy.


Cell & Gene Therapy Insights:

BROCHURE | Cell and Gene Therapy Analytical Development Services
Take the Video Tour | Our Gene Therapy Analytical Expertise
Article | Assessing Critical Quality Attributes of Viral Vectors
Case Study | Determining the Proportion of DNA-Packaged and Empty Capsid Populations by Cryo-TEM in Adeno-associated Viruses
Article | Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
Webinar | A Comparison of qPCR and ddPCR Methods for Residual DNA Analysis

Looking forward to connecting with you at the global cell and gene therapy conference in 2025 - in the meantime, please take a moment to learn more:
Our experts help you to confirm identity and ensure the product safety, quality, purity, potency and strength of your atmp or gene therapy product through GCP/GLP bioanalysis, stability storage and testing, compendial testing, viral vector characterisation, virology assays, aggregation analysis, cell-based assays / potency testing, QC release testing, advanced delivery technology analytical support and determination of residual proteins, DNA, RNA, cytokines, growth factors, serum, antibodies and solvents.


Need help or have a question?

Related Links

Contact Intertek